Prices, Markets and the Pharmaceutical Revolution
Pharmaceutical Price Controls and the Medicare Drug Benefit
Friday, January 28, 2000 | 4:00 p.m. – 5:00 p.m.
Wohlstetter Conference Center, Twelfth Floor, AEI 1150 Seventeenth Street, N.W., Washington, D.C. 20036
  • Print
  • Download
    Download
About This Event

Pharmaceutical price controls have become a controversial political issue. Numerous federal and state legislators have proposed reducing pharmaceutical prices by various methods. President Clinton's proposed out-patient drug benefit for Medicare-with special mechanisms for negotiating drug prices--is expected to be one of the high-visibility legislative proposals Congress considers in this election year.

At this event, John E. Calfee will brief the press on the findings of his timely new study

Prices, Markets, and the Pharmaceutical Revolution (AEI, 2000). He will comment on rapidly rising pharmaceutical expenditures, the sources of the ongoing pharmaceutical research revolution, and the threat of price controls. He will also present reasonable solutions for Medicare coverage for pharmaceuticals.

Patricia Danzon, author of

Pharmaceutical Price Regulation: National Policies versus Global Interests (AEI, 1997) and Price Comparisons for Pharmaceuticals; A Review of U.S. and Cross-National Studies (AEI, 1999), will address current controversies over pharmaceutical prices here and abroad and proposals to regulate U.S. prices.
Agenda

2:30 p.m.

Registration

3:00

Moderator:

Karlyn H. Bowman, AEI

Speakers:

John E. Calfee, AEI

Patricia Danzon, Wharton School, University of Pennsylvania, and AEI adjunct scholar

3:15

Q & A

4:00
Adjournment
AEI Participants

 

Karlyn
Bowman
  • Karlyn Bowman compiles and analyzes American public opinion using available polling data on a variety of subjects, including the economy, taxes, the state of workers in America, environment and global warming, attitudes about homosexuality and gay marriage, NAFTA and free trade, the war in Iraq, and women's attitudes. In addition, Ms. Bowman has studied and spoken about the evolution of American politics because of key demographic and geographic changes. She has often lectured on the role of think tanks in the United States and writes a weekly column for Forbes.com.
  • Phone: 2028625910
    Email: kbowman@aei.org

  • Assistant Info

    Name: Andrew Rugg
    Phone: 2028625917
    Email: andrew.rugg@aei.org
Show More | See Full Profile

 

John E.
Calfee

  • Economist John E. Calfee (1941-2011) studied the pharmaceutical industry and the Food and Drug Administration (FDA), along with the economics of tobacco, tort liability, and patents. He previously worked at the Federal Trade Commission's Bureau of Economics. He had also taught marketing and consumer behavior at the business schools of the University of Maryland at College Park and Boston University. While Mr. Calfee's writings are mostly on pharmaceutical markets and FDA regulation, his academic articles and opinion pieces covered a variety of topics, from patent law and tort liability to advertising and consumer information. His books include Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Biotechnology and the Patent System (AEI Press, 2007). Mr. Calfee wrote regularly for AEI's Health Policy Outlook series. He testified before Congress and federal agencies on various topics, including alcohol advertising; biodefense vaccine research; international drug prices; and FDA oversight of drug safety.

Show More
AEI on Facebook